361 related articles for article (PubMed ID: 34440663)
1. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
[TBL] [Abstract][Full Text] [Related]
2. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.
Keutgen XM; Nilubol N; Agarwal S; Welch J; Cochran C; Marx SJ; Weinstein LS; Simonds WF; Kebebew E
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):701-707. PubMed ID: 27464610
[TBL] [Abstract][Full Text] [Related]
3. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.
Nilubol N; Weisbrod AB; Weinstein LS; Simonds WF; Jensen RT; Phan GQ; Hughes MS; Libutti SK; Marx S; Kebebew E
World J Surg; 2013 Aug; 37(8):1966-72. PubMed ID: 23722465
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
Coutinho FL; Lourenço DM; Toledo RA; Montenegro FL; Correia-Deur JE; Toledo SP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):462-8. PubMed ID: 19650788
[TBL] [Abstract][Full Text] [Related]
5. Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.
Sharma J; Itum DS; Moss L; Li C; Weber C
World J Surg; 2014 Jun; 38(6):1268-73. PubMed ID: 24744114
[TBL] [Abstract][Full Text] [Related]
6. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
[TBL] [Abstract][Full Text] [Related]
7. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
8. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
[TBL] [Abstract][Full Text] [Related]
11. Clinical profile of juvenile primary hyperparathyroidism: a prospective study.
Saponaro F; Marcocci C; Cacciatore F; Miccoli M; Pardi E; Borsari S; Materazzi G; Miccoli P; Cetani F
Endocrine; 2018 Feb; 59(2):344-352. PubMed ID: 28527123
[TBL] [Abstract][Full Text] [Related]
12. Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.
Romero Arenas MA; Morris LF; Rich TA; Cote GJ; Grubbs EG; Waguespack SG; Perrier ND
J Pediatr Surg; 2014 Apr; 49(4):546-50. PubMed ID: 24726110
[TBL] [Abstract][Full Text] [Related]
13. Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
Giusti F; Cianferotti L; Gronchi G; Cioppi F; Masi L; Faggiano A; Colao A; Ferolla P; Brandi ML
Endocrine; 2016 Jun; 52(3):495-506. PubMed ID: 26224587
[TBL] [Abstract][Full Text] [Related]
14. Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?
Ohe MN; Bonanséa TCP; Santos RO; Neves MCD; Santos LM; Rosano M; Kunii IS; Castro ML; Vieira JGH
Arch Endocrinol Metab; 2019 Jul; 63(4):394-401. PubMed ID: 31365627
[TBL] [Abstract][Full Text] [Related]
15. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.
Kaji H; Nomura R; Yamauchi M; Chihara K; Sugimoto T
Horm Metab Res; 2006 Jun; 38(6):411-6. PubMed ID: 16823724
[TBL] [Abstract][Full Text] [Related]
17. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
[TBL] [Abstract][Full Text] [Related]
18. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
[TBL] [Abstract][Full Text] [Related]
19. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
Nilubol N; Weinstein LS; Simonds WF; Jensen RT; Marx SJ; Kebebew E
Ann Surg Oncol; 2016 Feb; 23(2):416-23. PubMed ID: 26542588
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
Ardawi MS; Al-Sibiany AM; Bakhsh TM; Rouzi AA; Qari MH
Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
